Avantor Posts $1.7B in Third-Quarter Sales
AVTR has more than doubled off its 52-week low of $7.265.
Summary
Avantor reported third-quarter net sales of $1,698.3M, up 4.6% with organic growth of 5.2%, along with EPS of 30c and adjusted EPS of USD 0.22 versus an IBES estimate of USD 0.21. Free cash flow was $156.2M, and the company raised its FY26 free cash flow guidance to $525M-$550M. It narrowed its FY26 view to adjusted EPS of 81c to 83c and raised its FY26 organic revenue growth outlook to +0.75% to +1.25%. Context still matters: Q2 net income fell sharply on a tax charge and management flagged a high goodwill impairment risk in the VWR Distribution unit, so the earnings quality question remains open. The stock sits near its 52-week high of $17.45, meaning expectations are elevated and the bar for the quarter is higher than the revenue print implies.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Avantor's Q3 net sales rose 4.6% to $1,698.3M with organic growth of 5.2%; free cash flow was $156.2M and FY26 free cash flow guidance rose to $525M-$550M.
At the time of this announcement, AVTR was trading at $16.85 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $7.27 to $17.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.